| Financial Year |
March 31 2023 |
| Monetary Funds |
5,392,432,742.78 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,074,808,312.00 |
| Accounts Receivable |
6,303,516,070.63 |
| Advances to Suppliers |
287,927,920.23 |
| Other Receivables |
288,675,330.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,976,647,319.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
544,203,020.47 |
| Total Current Assets |
17,843,218,376.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
26,208,237.32 |
| Long-term Equity Investment |
509,817,821.34 |
| Investment Properties |
446,930,781.84 |
| Fixed Assetes |
5,049,054,140.01 |
| Under-construction Projects |
386,258,236.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,153,561,421.94 |
| R&D expenses |
2,086,556,346.13 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
21,753,204.77 |
| Deferred Income Tax Assets |
749,297,875.73 |
| Other Non-Current Assets |
100,513,916.27 |
| Sub-Total of Non-Current Assets |
13,473,791,560.43 |
| Total Assets |
31,317,009,937.02 |
| Short-Term Loans |
6,574,866,822.53 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,122,248,999.56 |
| Accounts Payable |
4,152,365,507.52 |
| Accounts Received In Advance |
14,807,760.46 |
| Employee Compensation Payable |
107,198,203.94 |
| Taxes Payable |
52,219,875.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,169,247,715.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,633,108,815.90 |
| Other Current Liabilities |
241,981,809.00 |
| Sub-Total of Current Liabilities |
19,439,018,631.96 |
| Long-term Loans |
4,607,594,820.54 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
520,660,636.04 |
| Special Payable |
-- |
| Estimatied Liabilities |
251,675,667.55 |
| Deferred Income Tax Liabilities |
2,430,595.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,500,735,487.27 |
| Total Liabilities |
25,939,754,119.23 |
| Paid-In Capital(Or Share Stock) |
4,287,310,130.00 |
| Capital Surplus |
18,764,461,266.96 |
| Surplus Reserve |
3,482,729.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-18,271,916,526.15 |
| Minority Stockholder's Interest |
639,978,601.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,737,277,216.03 |
| Owner's Equity（Stockholder's Equity） |
5,377,255,817.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
31,317,009,937.02 |
